To Ease Long-Term Drug Pricing Pressure, Extend Patent Terms by 10 Years Now
Congress protects song lyrics for nearly a century. Yet life-saving medical inventions, the result of years of scientific risk and billions in investment, expire after just 20 years from filing. That imbalance isn’t just hard to justify. It’s quietly driving up drug prices and weakening incentives for innovation where America needs it most.
TL;DR
- Developing a new drug costs over $2 billion and takes more than a decade, with much of the patent term lost to regulatory approval.
- Copyrights for creative works last much longer (life of author + 70 years) with significantly lower investment.
- A 10-year extension of patent terms would better reflect the economic realities of pharmaceutical innovation.
- Longer patent protection would strengthen incentives for research and development in high-risk areas like oncology and rare diseases.
- Extending patent terms could ease pressure for front-loaded high pricing, allowing for more stable pricing and better patient access over time.
- The current system can lead to companies recovering costs over a compressed exclusivity window, driving up launch prices.